Table of Contents

2017 Month : September Volume : 6 Issue : 77 Page : 5474-5477

CYTOKERATIN 19 IMMUNOREACTIVITY IN PAPILLARY THYROID CARCINOMA.

Chithira Balakrishnan1, Sheela Varghese2, Sankar S3

1Senior Resident, Department of Pathology, Government Medical College, Kottayam.
2Associate Professor, Department of Pathology, Government Medical College, Kottayam.
3Professor and HOD, Department of Pathology, Government Medical College, Kottayam.

References :

1

Sahoo S, Hoda SA, Rosai J, et al. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol 2001;116(5):696–702.         

CrossRef | Google Scholar | PubMed
2

Bose D, Das RN, Chatterjee U, et al. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma. Indian J Med Paediatr Oncol 2012;33(2):107-11.

CrossRef | Google Scholar | PubMed
3

Negri E, Dal Maso L, Ron E, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 1999;10(2):143–55.               

CrossRef | Google Scholar | PubMed
4

DeLellis RA, Lloyd RV, Heitz PU, et al. Pathology and genetics of tumours of endocrine organs. In: Kleihues P, Sobrin LH, (eds). World Health Organization. Classification of tumours. Lyon: IARC Press, 2004:49-66.

5

Sharma C. An analysis of trends of incidence and cytohistological correlation of papillary carcinoma of the thyroid gland with evaluation of discordant cases. J Cytol 2016;33(4):192-8.            

CrossRef | Google Scholar | PubMed
6

Alshenawy HA. Utility of immunohistochemical markers in differential diagnosis of follicular cell derived thyroid lesions. Journal of Microscopy and Ultrastructure 2014;2(3):127-36.                  

CrossRef | Google Scholar |
7

Tamimi DM. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 2002;10(2):141-6.            

CrossRef | Google Scholar | PubMed
8

Saleh HA, Jin B, Barnwell J, et al. Utility of IHC markers in differentiating benign from malignant follicular derived thyroid nodules. Diagn Pathol 2010;5:9.                    

CrossRef | Google Scholar | PubMed